Copyright
©The Author(s) 2018.
World J Hepatol. Oct 27, 2018; 10(10): 743-751
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.743
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.743
Countries and approving bodies | Yr Recommendations approved | Abnormal Aminotransferases | Acute hepatitis or hepatitis symptoms | Being immunized/receiving a medical procedure in a specified country where hepatitis C is common or lack of universal precautions | Birth cohort/age recommendations or one-time testing for all | Blood/clotting factor transfusion Patients/ Transplant Patients | Body Piercing or Tattoo History | Children born to HCV-infected mothers (expectant mothers) | Chronic liver disease, cirrhosis,or fibrosis | Contact tracing /exposure to infected blood, shared hygiene materials with HCV + person | Donors - blood, blood product,tissue or organ | Drug users - injecting | BDrug users - intranasal | Healthcare workers (public safety) at risk and/or post-exposure | Hemodialysis history or repeatedpercutaneous injections | Hemophilia history | Hepatitis A or B history (or non-A/non-B hepatitis) | HIV-positive patients | Homeless | Immigrants or visitors from countrieswhere HCV is endemic | Incarceration history alone or with additional risk factors | Liver cancer | Living with or sexual partner ofHCV-positive person | MSM, limited to HIV + MSM (with or without unprotected sex), or sexually active starting PrEP | Multiple Sex Partners, history of STIs, or high risk sexual behaviors | Patient request, percutaneous-parenteral exposure, prior positive HCV test | STI clinic (+/- any risk factors) |
Argentina | 2016 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
Dirección de Sida y ETS, Ministerio de Salud de la Nación | |||||||||||||||||||||||||||
Australia | 2016 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||
National HCV Testing Policy Expert Reference Committee | |||||||||||||||||||||||||||
Canada | 2017 and 2009 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
Canadian Task Force on Preventive Health Care | |||||||||||||||||||||||||||
Chile | 2015 | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||||
Ministerio de Salud de Chile (Chilean Ministry of Health) | |||||||||||||||||||||||||||
Denmark | 2013 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
Sundhedsst-yrelsen (Danish Health Authority) | |||||||||||||||||||||||||||
Finland | 2016 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
Sosiaali- ja terveysministeriö (Social and Health Ministry) | |||||||||||||||||||||||||||
France | 2014 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||
ANRS/AFEF with Ministère des Affaires sociales et de la Santé (Ministry of Social Affairs and Health) | |||||||||||||||||||||||||||
Greece | 2017 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
Υπουργειο ΥγειαΣ (Ministry of Health) | |||||||||||||||||||||||||||
Ireland | 2012 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||
Feidhmeannacht na Seirbhise Slainte | |||||||||||||||||||||||||||
Italy | 2005 | X | X | X | X | X | X | ||||||||||||||||||||
Istituto Superiore di Sanità | |||||||||||||||||||||||||||
Japan | 2011 | X | |||||||||||||||||||||||||
Ministry of Health, Labour and Welfare | |||||||||||||||||||||||||||
Russian Federation | 2017 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
Министерство здравоохранения (Ministry of Health) | |||||||||||||||||||||||||||
Spain | 2015 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||||||||||
Ministeriode Sanidad, Servicios Socialese Igualdad (Ministry of Health, Social Services and Equality) | |||||||||||||||||||||||||||
Switzerland | 2013 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||
Bundesamt für Gesundheit (Swiss Federal Office of Public Health) | |||||||||||||||||||||||||||
United Kingdom | 2015 and 2012 | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||||
NHS and National Inst for Health and Care Excellence | |||||||||||||||||||||||||||
United States | 2017 | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | |||||||||||
HCV Guidance Panel |
- Citation: Irvin R, Ward K, Agee T, Nelson NP, Vellozzi C, Thomas DL, Millman AJ. Comparison of hepatitis C virus testing recommendations in high-income countries. World J Hepatol 2018; 10(10): 743-751
- URL: https://www.wjgnet.com/1948-5182/full/v10/i10/743.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i10.743